Recent Updates
Recently added Catalysts
COO Positive Sentiment

CooperCompanies Announces Release Date for Third Quarter 2026

Thursday, July 30, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: CooperCompanies has announced the release date for its third quarter 2026 financial results, which will be reported on September 9, 2026. Following the announcement, a conference call will be held to discuss the results and corporate developments. The company continues to emphasize its commitment to healthcare through its business units.

Market Sentiment Analysis

POSITIVE FACTORS

  • CooperCompanies is set to report its financial results, indicating ongoing business activity.
  • The company continues to engage with investors through a scheduled conference call.
  • CooperCompanies has a strong global presence and a significant impact on healthcare.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+8%
120-day peak, hindsight
Typical move
1%
average across 2 past catalysts
Cash runway
~12 mo
Medium dilution risk
Lead asset
Normal saline ,Control
Phase 3 · Migraine Headache

Full Press Release Details

SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 9708839. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com
Contact:

Frequently Asked Questions

When will CooperCompanies announce its Q3 2026 results?

CooperCompanies will announce its Q3 2026 financial results on September 9, 2026.

What time is the conference call for Q3 results?

The conference call will take place at 5:00 PM ET on September 9, 2026.

How can I access the conference call?

You can dial 800-715-9871 and use conference ID 9708839 to join the call.

Where can I find more information about CooperCompanies?

More information can be found on their official website at www.coopercos.com.

ShareAdd on Google
Tags: COO Viatris Investor Conferences Healthcare CooperCompanies financial results conference call medical device
Last updated: Jul 30, 2026

Biotech snapshot

Cash runway
$139M liquidity · $10M/mo burn
~12 mo
Medium dilution risk
Lead asset
Normal saline ,ControlPhase 3
Migraine Headache →

Catalyst track record

+8%
best trade around COO's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for COO.

See every catalyst's timing & PoA →